WWM
LGND icon

Willingdon Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

Willingdon Wealth Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-107
Closed -$9K – 378
2018
Q4 		$9K Sell
107
-465
-81% -$49.6K ﹤0.01% 267
2018
Q3 		$98K Hold
572
– – 0.03% 160
2018
Q2 		$74K Sell
572
-25,028
-98% -$2.79M 0.02% 167
2018
Q1 		$2.64M Buy
25,600
+1,435
+6% +$142K 0.83% 50
2017
Q4 		$2.06M Buy
24,165
+633
+3% +$54.9K 0.68% 62
2017
Q3 		$2M Buy
23,532
+763
+3% +$60.4K 0.73% 61
2017
Q2 		$1.72M Buy
22,769
+309
+1% +$21.6K 0.68% 70
2017
Q1 		$1.48M Buy
22,460
+1,021
+5% +$67.2K 0.6% 68
2016
Q4 		$1.36M Buy
21,439
+767
+4% +$48.4K 0.64% 65
2016
Q3 		$1.32M Buy
20,672
+7,050
+52% +$518K 0.66% 72
2016
Q2 		$1.01M Buy
13,622
+1,067
+8% +$79.2K 0.52% 79
2016
Q1 		$839K Sell
12,555
-6,885
-35% -$418K 0.51% 69
2015
Q4 		$1.31M Buy
19,440
+847
+5% +$52.3K 1.2% 42
2015
Q3 		$993K Sell
18,593
-175
-0.9% -$10.6K 1.18% 42
2015
Q2 		$1.18M Buy
+18,768
New +$1.02M 1.13% 45

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Willingdon Wealth Management's LGND Position: Q1 2019 in Review

Willingdon Wealth Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2019, closing a stake of 107 shares — an estimated $9K sold.

Willingdon Wealth Management first reported a position in LGND in Q2 2015 and held it in 15 quarters. The position peaked at $2.64M in Q1 2018. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

  • Willingdon Wealth Management reported no remaining Ligand Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Willingdon Wealth Management sold 107 Ligand Pharmaceuticals shares in Q1 2019, an estimated $9K.
  • Willingdon Wealth Management first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 15 quarters.
  • Willingdon Wealth Management's Ligand Pharmaceuticals position peaked at $2.64M in Q1 2018.
  • 330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on Willingdon Wealth Management's 13F filing for Q1 2019, filed 9 May 2019.